Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 7, 2023; 29(1): 157-170
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Table 5 Summary of efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic tumors
Procedure | EUS-guided RFA for pancreatic | ||
Neuroendocrine tumors | Adenocarcinoma | Cystic tumors | |
Technical success | High | High | High |
Safety, complications | Mild-moderate1 | Mild | Mild |
Efficacy | |||
Clinical improvement | Significant for insulinomas | None | - |
Radiological partial/complete resolution | High | Modest | Encouraging |
Palliation | - | Encouraging | - |
Mortality | None | None | None |
- Citation: Khoury T, Sbeit W, Napoléon B. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies. World J Gastroenterol 2023; 29(1): 157-170
- URL: https://www.wjgnet.com/1007-9327/full/v29/i1/157.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i1.157